WASHINGTON: PhRMA said that Wes Metheny has been named acting head of public affairs and communications, following the departure of Ken Johnson, SVP of communications and public affairs.
The pharmaceutical trade group said that Johnson left PhRMA in August, following the exits earlier this year of Billy Tauzin, president and CEO, and Mimi Simoneaux Kneuer, former EVP of government and public affairs.
The drug lobby's new president and CEO John Castellani started September 1.
Metheny, most recently SVP of alliances, affordability, and access at PhRMA, has been with the association for 11 years. He said that Castellani is reviewing "the overall structure of PhRMA," including communications, which employs a staff of 16.
"We're in a transition at PhRMA," he said.
Chip Davis, VP of corporate external relations at AstraZeneca, is still supporting the leadership transition at PhRMA. The trade association brought him in in April.
When asked about agency relationships, Metheny said that PhRMA reviews its agencies on an annual basis and there are no formal plans to review them as a result of the leadership changes at the trade group.